Science 37
Latest round
- Series D
Last raised
- Aug 2020
Total raised
- $107M
Investors
- 11
About Science 37
, provides universal access to clinical research enabling patients and providers to participate in accelerating the development of new treatments. In 2020, Science 37, Inc.05 billion with a USD 200 million PIPE proceed. As of 2021, the company conducts over 95 decentralized clinical trials, engaging over 366,000 patients, and staffs over 500 employees., provides universal access to clinical research enabling patients and providers to participate in accelerating the development of new treatments. In 2020, Science 37, Inc.05 billion with a USD 200 million PIPE proceed. As of 2021, the company conducts over 95 decentralized clinical trials, engaging over 366,000 patients, and staffs over 500 employees. Science37’s operating system is fully configurable allowing researchers to activate the patient engagement network or accessing the company’s network of telemedicine investigators. The company’s DCT OS supports any phase of study from pivot trials and RWE studies for a wide range of indications such as oncology, CNS, endocrinology, pediatrics, infectious, and rare diseases. Science37’s DCT OS™ offers mobile nurses, remote coordinators, patient communities, and connected devices. Post the merger between Science37 Inc and LifeSci Acquisition II Corp, the combined company will operate as Science37 and plans to list on the NASDAQ under the ticker symbol SNCE. The company plans on advancing its OS to further penetrate adjacent markets and power the future of clinical research.
Who invested in Science 37
11 investors across 4 rounds
See all investors in Science 37
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Science 37
Who invested in Science 37?
Science 37 has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Science 37 raised?
Science 37 has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Science 37 last raise money?
Science 37's most recent round on record is a Series D, in Aug 2020.
What does Science 37 do?
, provides universal access to clinical research enabling patients and providers to participate in accelerating the development of new treatments.
Where is Science 37 headquartered?
Science 37 is headquartered in Culver City, US.
Which VCs invest in companies like Science 37?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Science 37's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series D
Raising like Science 37? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.